The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Recent developments in the design of angiotensin‐converting enzyme inhibitors
Abstract
Orally-active angiotensin-converting enzyme inhibitors are rapidly establishing themselves in the therapy of hypertension and congestive heart failure. Concerted efforts in a number of laboratories have now led to the discovery or synthesis of an unparalleled variety of potent inhibitors. The manner in which several of these inhibitors bind to ACE is beginning to be understood. It is hoped that some of the insights to be derived from the SAR and structural studies done with ACE inhibitors will be applicable to other enzyme targets as well. The success of ACE inhibitors as pharmacological tools and in the clinic will also quite certainly encourage future efforts to develop new enzyme inhibitor approaches to drug therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Cushman, D. W., Cheung, H. S., Sabo, E. F., & Ondetti, M. A. (1977) · Biochemistry · doi:10.1021/bi00644a014 · Cited by 892
Cheung, H. S., Wang, F. L., Ondetti, M. A., Sabo, E. F., & Cushman, D. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86187-2 · Cited by 745
A new class of angiotensin-converting enzyme inhibitors
Patchett, A. A., Harris, E., Tristram, E. W., Wyvratt, M. J., Wu, M. T., Taub, D., Peterson, E. R., Ikeler, T. J., ten Broeke, J., Payne, L. G., et al. (1980) · Nature · doi:10.1038/288280a0 · Cited by 699
Self-citationChemistry and Biology of Peptides
Gitu, P. M., Hruby, V., Brown, W. S., & Muscio, F. (1972) · Cited by 614
Ondetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
Ferreira, S. H., Bartelt, D. C., & Greene, L. J. (1970) · Biochemistry · doi:10.1021/bi00815a005 · Cited by 513
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
J.P. (1971) · Toxicon · doi:10.1016/0041-0101(71)90098-5 · Cited by 480
Enzymes of the Renin-Angiotensin System and their Inhibitors
Ondetti, M. A., & Cushman, D. W. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.001435 · Cited by 467
Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase
Skidgel, R. A., Engelbrecht, S., Johnson, A. R., & Erdös, E. G. (1984) · Peptides · doi:10.1016/0196-9781(84)90020-2 · Cited by 458
Gavras, H., Brunner, H. R., Laragh, J. H., Sealey, J. E., Gavras, I., & Vukovich, R. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410172911603 · Cited by 353
Hangauer, D. G., Monzingo, A. F., & Matthews, B. W. (1984) · Biochemistry · doi:10.1021/bi00319a011 · Cited by 247
Progress in Medicinal Chemistry.
Burger, A. (1963) · Journal of Medicinal Chemistry · doi:10.1021/jm00342a061 · Cited by 231
A Peptide Inhibitor of Angiotensin I Converting Enzyme in the Tryptic Hydrolysate of Casein
Maruyama, S., & Suzuki, H. (1982) · Agricultural and Biological Chemistry · doi:10.1271/bbb1961.46.1393 · Cited by 223
Weaver, L. H., Kester, W. R., & Matthews, B. W. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90286-8 · Cited by 219
Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A
Byers, L. D., & Wolfenden, R. (1973) · Biochemistry · doi:10.1021/bi00735a008 · Cited by 195
Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions
Petrillo, E. W., & Ondetti, M. A. (1982) · Medicinal Research Reviews · doi:10.1002/med.2610020103 · Cited by 192
A THERMOLYSIN INHIBITOR PRODUCED BY ACTINOMYCETES: PHOSPHORAMIDON
SUDA, H., AOYAGI, T., TAKEUCHI, T., & UMEZAWA, H. (1973) · The Journal of Antibiotics · doi:10.7164/antibiotics.26.621 · Cited by 185
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE
Edwards, C. R. W., & Padfield, P. L. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90975-4 · Cited by 182
Case, D. B., Wallace, J. M., Keim, H. J., Weber, M. A., Drayer, J. I. M., White, R. P., Sealey, J. E., & Laragh, J. H. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90160-1 · Cited by 173
Cascieri, M. A., Bull, H. G., Mumford, R. A., Patchett, A. A., Thornberry, N. A., & Liang, T. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14945-6 · Cited by 168
Self-citationKato, H., & Suzuki, T. (1971) · Biochemistry · doi:10.1021/bi00782a007 · Cited by 160
Monzingo, A. F., & Matthews, B. W. (1984) · Biochemistry · doi:10.1021/bi00319a010 · Cited by 156
Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension
Ondetti, M. A., & Cushman, D. W. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00136a001 · Cited by 146
Biollaz, J., Burnier, M., Turini, G. A., Brunner, D. B., Porchet, M., Gomez, H. J., Jones, K., Ferber, F., Abrams, W. B., Gavras, H. P., et al. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.92 · Cited by 145
Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase.
El-Dorry, H. A., Bull, H. G., Iwata, K., Thornberry, N. A., Cordes, E. H., & Soffer, R. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45353-2 · Cited by 136
Design of potent and specific inhibitors of carboxypeptidases A and B
Ondetti, M. A., Condon, M. E., Reid, J., Sabo, E. F., Cheung, H. S., & Cushman, D. W. (1979) · Biochemistry · doi:10.1021/bi00575a006 · Cited by 118
Enalapril Worldwide Experience
Davies, R. O., Irvin, J. D., Kramsch, D. M., Walker, J. F., & Moncloa, F. (1984) · The American Journal of Medicine · doi:10.1016/s0002-9343(84)80055-8 · Cited by 102
A Potent Reversible Inhibitor of Carboxypeptidase A
Byers, L. D., & Wolfenden, R. V. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45746-3 · Cited by 91
McCoubrey-Hoyer, A., OKARMA, T. B., & Holman, H. R. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90431-5 · Cited by 91
Angiotensin-Converting Enzyme Inhibitors: Biochemical Properties and Biological Action
Ondetti, M. A., Cushman, D. W., & Soffer, R. L. (1984) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238409108720 · Cited by 76
Bush, K., Henry, P. R., & SLUSARCHYK, D. S. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.330 · Cited by 57
Inhibition of thermolysin by N-carboxymethyl dipeptides
Maycock, A. L., DeSousa, D. M., Payne, L. G., et al. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91632-6 · Cited by 56
Angiotensin-Converting Enzyme Inhibitors in the Treatment of Hypertension
Johnston, C. I., Arnolda, L., & Hiwatari, M. (1984) · Drugs · doi:10.2165/00003495-198427030-00006 · Cited by 54
Couture, R., & Regoli, D. C. (1981) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y81-096 · Cited by 47
Almquist, R. G., Crase, J., Jennings-White, C. L. D., Meyer, R. F., Hoefle, M. L., Smith, R. D., Essenburg, A. D., & KAPLAN, H. R. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00353a005 · Cited by 43
Bolognesi, M., & Matthews, B. W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37852-3 · Cited by 41
Unger, T., Yukimura, T., Marin-Grez, M., Lang, R. E., Rascher, W., & Ganten, D. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90483-6 · Cited by 36
Klutchko, S. R., Hoefle, M. L., Smith, R. D., Essenburg, A. D., Parker, R. B., Nemeth, V. L., Ryan, M. J., Dugan, D. H., & KAPLAN, H. R. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00133a021 · Cited by 35
The design of a new group of angiotensin‐converting enzyme inhibitors
Hassall, C. H., Kröhn, A., Moody, C. J., & Thomas, W. A. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81036-3 · Cited by 35
Hypertension and the Angiotensin System: Therapeutic Approaches
Doyle, A. E., & Bearn, A. G. (1984) · Medical Entomology and Zoology · Cited by 23
Cited by
Prescribed drugs containing nitrogen heterocycles: an overview
Heravi, M. M., & Zadsirjan, V. (2020) · RSC Advances · doi:10.1039/d0ra09198g · Cited by 1,194
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
Peptidomimetics—Tailored Enzyme Inhibitors
Gante, J. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199416991 · Cited by 825
Development and biological activities of marine-derived bioactive peptides: A review
Kim, S.-K., & Wijesekara, I. (2010) · Journal of Functional Foods · doi:10.1016/j.jff.2010.01.003 · Cited by 777
Hypotensive Peptides from Milk Proteins
FitzGerald, R. J., Murray, B. A., & Walsh, D. J. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.4.980s · Cited by 724
Metadata
- Authors
- Wyvratt, M. J., & Patchett, A. A.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 1985-10
- Volume
- 5
- Issue
- 4
- Pages
- 483-531
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W1985090509
- Cited by
- 253
- References
- 42
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.